About Clinical MSCh No1
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Clinical MSCh No1
During the past decade, Clinical MSCh No1 conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical MSCh No1"
#1 collaborator was "AbbVie" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Clinical MSCh No1
According to Clinical.Site data, the most researched conditions in "Clinical MSCh No1" are
"Lymphocytic Leukemia, Chronic" (2 trials) and "Lymphoma, Large B-Cell, Diffuse" (1 trials). Many other conditions were trialed in "Clinical MSCh No1" in a lesser frequency.
Clinical Trials Intervention Types at Clinical MSCh No1
Most popular intervention types in "Clinical MSCh No1" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "CHOP" (1 trials), "Chlorambucil" (1 trials), "Cyclophosphamide" (1 trials), "Fludarabine" (1 trials) and "Obinutuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinical MSCh No1
The vast majority of trials in "Clinical MSCh No1" are
3 trials for "All" genders.
Clinical Trials Status at Clinical MSCh No1
Currently, there are NaN active trials in "Clinical MSCh No1".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Clinical MSCh No1,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Clinical MSCh No1, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".